Company intelligence / Profile preview

Medisave Pharmaceutical

Lahore, Punjab, Pakistanmedisave.net ↗

Ownership: Private
Development stage: Other

Overview

Medisave Pharmaceutical operates a large-scale manufacturing business with over 25,000 products across various disease categories. It reports significant monthly sales (~Rs. 100 million) and exports to several countries. The company has announced plans to establish Pakistan’s first biotech plant for cancer treatment and expand into vaccine manufacturing within five years.

Therapeutic areas: Infectious DiseasesOncologyOther
Industry: Biotech

Beyond the preview

Go deeper on Medisave Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medisave Pharmaceutical.

Explore the full profile